Literature DB >> 25864650

Efficacy-oriented compatibility for component-based Chinese medicine.

Jun-hua Zhang1, Yan Zhu1, Xiao-hui Fan2, Bo-li Zhang3.   

Abstract

Single-target drugs have not achieved satisfactory therapeutic effects for complex diseases involving multiple factors. Instead, innovations in recent drug research and development have revealed the emergence of compound drugs, such as cocktail therapies and "polypills", as the frontier in new drug development. A traditional Chinese medicine (TCM) prescription that is usually composed of several medicinal herbs can serve a typical representative of compound medicines. Although the traditional compatibility theory of TCM cannot be well expressed using modern scientific language nowadays, the fundamental purpose of TCM compatibility can be understood as promoting efficacy and reducing toxicity. This paper introduces the theory and methods of efficacy-oriented compatibility for developing component-based Chinese medicines.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25864650      PMCID: PMC4594187          DOI: 10.1038/aps.2015.8

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  26 in total

Review 1.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

Review 2.  Target-based drug discovery: is something wrong?

Authors:  Frank Sams-Dodd
Journal:  Drug Discov Today       Date:  2005-01-15       Impact factor: 7.851

3.  Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.

Authors:  S Yusuf; P Pais; R Afzal; D Xavier; K Teo; J Eikelboom; A Sigamani; V Mohan; R Gupta; N Thomas
Journal:  Lancet       Date:  2009-03-30       Impact factor: 79.321

Review 4.  Shifting from the single to the multitarget paradigm in drug discovery.

Authors:  José L Medina-Franco; Marc A Giulianotti; Gregory S Welmaker; Richard A Houghten
Journal:  Drug Discov Today       Date:  2013-01-20       Impact factor: 7.851

5.  Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation--rationale, methods and preliminary results from a Sino-American collaboration.

Authors:  David M Eisenberg; Eric S J Harris; Bruce A Littlefield; Shugeng Cao; Jane A Craycroft; Robert Scholten; Peter Bayliss; Yanling Fu; Wenquan Wang; Yanjiang Qiao; Zhongzhen Zhao; Hubiao Chen; Yong Liu; Ted Kaptchuk; William C Hahn; Xiaoxing Wang; Thomas Roberts; Caroline E Shamu; Jon Clardy
Journal:  Fitoterapia       Date:  2010-11-22       Impact factor: 2.882

6.  Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease.

Authors:  Michael Krauthammer; Charles A Kaufmann; T Conrad Gilliam; Andrey Rzhetsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-07       Impact factor: 11.205

7.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

8.  A combined approach to data mining of textual and structured data to identify cancer-related targets.

Authors:  Pavel Pospisil; Lakshmanan K Iyer; S James Adelstein; Amin I Kassis
Journal:  BMC Bioinformatics       Date:  2006-07-20       Impact factor: 3.169

9.  Identifying roles of "Jun-Chen-Zuo-Shi" component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology.

Authors:  Leihong Wu; Yi Wang; Zheng Li; Boli Zhang; Yiyu Cheng; Xiaohui Fan
Journal:  Chin Med       Date:  2014-09-16       Impact factor: 5.455

10.  Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial.

Authors:  Hongcai Shang; Junhua Zhang; Chen Yao; Baoyan Liu; Xiumei Gao; Ming Ren; Hongbao Cao; Guohua Dai; Weiliang Weng; Sainan Zhu; Hui Wang; Hongjuan Xu; Boli Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-14       Impact factor: 2.629

View more
  18 in total

1.  Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine.

Authors:  Dayue Darrel Duan; Zhong Wang; Bo-li Zhang; Yong-yan Wang
Journal:  Acta Pharmacol Sin       Date:  2015-06       Impact factor: 6.150

Review 2.  Full genetic analysis for genome-wide association study of Fangji: a powerful approach for effectively dissecting the molecular architecture of personalized traditional Chinese medicine.

Authors:  Gang Chen; Wen-da Xue; Jun Zhu
Journal:  Acta Pharmacol Sin       Date:  2018-02-08       Impact factor: 6.150

3.  A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi.

Authors:  Jiahui Yu; Wen Zhang; Yiqian Zhang; Yadong Wang; Boli Zhang; Guanwei Fan; Yan Zhu
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

4.  Detoxication mechanisms of Radix Tripterygium wilfordii via compatibility with Herba Lysimachia christinae in S180-bearing mice by involving Nrf2.

Authors:  Jun-Ming Wang; Hong Cai; Jin-Hua Li; Rong-Xing Chen; Yue-Yue Zhang; Jin-Yang Li; Ning-Ning Ding; Chen Liu; Ying Cui
Journal:  Biosci Rep       Date:  2018-07-12       Impact factor: 3.840

5.  Study on Cardiotoxicity and Mechanism of "Fuzi" Extracts Based on Metabonomics.

Authors:  Guangyao Huang; Liang Yang; Wei Zhou; Xianglin Tang; Yuguang Wang; Zengchun Ma; Shan Gao; Yue Gao
Journal:  Int J Mol Sci       Date:  2018-11-07       Impact factor: 5.923

Review 6.  Assessing the methodological and reporting quality of network meta-analyses in Chinese medicine.

Authors:  Fengwen Yang; Hucheng Wang; Jiahan Zou; Xuemei Li; Xinyao Jin; Yawen Cao; Jinhui Tian; Long Ge; Myeong Soo Lee; Junhua Zhang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

7.  A Novel Method for Evaluating the Cardiotoxicity of Traditional Chinese Medicine Compatibility by Using Support Vector Machine Model Combined with Metabonomics.

Authors:  Yubo Li; Haonan Zhou; Jiabin Xie; Mayassa Salum Ally; Zhiguo Hou; Yanyan Xu; Yanjun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-23       Impact factor: 2.629

8.  Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.

Authors:  Hengxia Zhao; Daocheng Zhou; Ye Chen; Deliang Liu; Shufang Chu; Shimao Zhang
Journal:  Daru       Date:  2017-10-11       Impact factor: 3.117

9.  Decomposing the Mechanism of Qishen Granules in the Treatment of Heart Failure by a Quantitative Pathway Analysis Method.

Authors:  Weiquan Ren; Sheng Gao; Huimin Zhang; Yinglu Ren; Xue Yu; Weili Lin; Shuzhen Guo; Ruixin Zhu; Wei Wang
Journal:  Molecules       Date:  2018-07-23       Impact factor: 4.411

10.  Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER+ breast cancer model.

Authors:  Fabia De Oliveira Andrade; Wei Yu; Xiyuan Zhang; Elissa Carney; Rong Hu; Robert Clarke; Kevin FitzGerald; Leena Hilakivi-Clarke
Journal:  Endocr Relat Cancer       Date:  2019-03-01       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.